Skip to main content
OpenTrials

Clinical trial condition

Eosinophilia

Explore clinical trials studying Eosinophilia. Study availability and eligibility vary by location and protocol.

264 public trials 42 recruiting studies
Refine in advanced search Browse all conditions

Eosinophilia trial results

Active, Not Recruiting

A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma

NCT05692180

Conditions
Asthma, Bronchial Diseases, Eosinophilia, +12 more
Locations
  • Research Site Torrance, California, United States
  • Research Site Ocala, Florida, United States
  • Research Site Owensboro, Kentucky, United States
  • Research Site Lafayette, Louisiana, United States
View all 43 locations
View Trial Details
Active, Not Recruiting

A Phase III Study to Evaluate the Efficacy and Safety of Benralizumab in Patients With Hypereosinophilic Syndrome (HES)

NCT04191304

Conditions
Eosinophilia, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Bethesda, Maryland, United States
  • Research Site Ann Arbor, Michigan, United States
View all 52 locations
View Trial Details
Active, Not Recruiting

A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May Have

NCT05831176

Conditions
Digestive System Diseases, Eosinophilia, Eosinophilic Duodenitis (EoD), +15 more
Locations
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Om Research LLC Apple Valley, California, United States
  • Scripps Clinic La Jolla, California, United States
  • Om Research LLC Lancaster, California, United States
View all 53 locations
View Trial Details
Active, Not Recruiting

A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 Weeks

NCT06851559

Conditions
Digestive System Diseases, Eosinophilia, Eosinophilic Esophagitis, +10 more
Locations
  • Preferred Research Partners, Inc Little Rock, Arkansas, United States
  • GW Research, Inc Chula Vista, California, United States
  • Southern California Research Institute Medical Group Los Angeles, California, United States
  • Rocky Mountain Gastroenterology Lakewood, Colorado, United States
View all 41 locations
View Trial Details

Related conditions